Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Gene Therapy Companies

Gene therapy is an innovative field that involves the introduction, modification, or correction of genetic material to treat or prevent diseases. Gene therapy companies focus on developing and commercializing gene-based treatments for various medical conditions.

Gene Therapy Key Companies Latest Gene Therapy Companies Update

November 2023: The Phase 1 REGENERATE MSA-101 clinical trial of AB-1005, a gene therapy aimed at treating multiple system atrophy-parkinsonian type (MSA-P), has recently commenced at the Ohio State University Wexner Medical Center. Asklepios BioPharmaceutical, Inc., a gene therapy company that operates as a subsidiary of Bayer AG, has announced the randomization of the first patient in this trial. This achievement represents a noteworthy advancement in the progress of AB-1005 gene therapy, which utilizes an adeno-associated viral vector known as AAV2-GDNF to encode glial cell line-derived neurotrophic factor. The delivery of this vector to the putamen region puts this therapeutic approach closer to its possible application in treating patients. The investigation of AB-1005 for the treatment of mild to moderate Parkinson's disease is now underway, with the completion of recruitment in the Phase 1b research.

November 2023: the Medicines and Healthcare Products Regulatory Agency of the United Kingdom issued conditional marketing authorization to Casgevy, a gene editing medication developed by Vertex Pharmaceuticals and CRISPR Therapeutics. This milestone represents the first approval of a therapy utilizing CRISPR-based gene editing technology. The authorization of Casgevy for the treatment of sickle cell anemia (SCA) and β-thalassaemia marks a significant milestone in the field of genetic diseases, signifying the emergence of a promising age in which the possibility of curing inherited problems becomes a viable prospect. This development brings hope to millions of individuals worldwide who are currently facing the challenges posed by these hereditary ailments. The primary constraint impeding the extensive use of this medication is its exorbitant expense. According to estimations, the projected cost per patient is roughly $2 million.List of Gene Therapy Key companies in the market

Amgen Inc. (US)

Spark Therapeutics Inc. (US)

Bristol-Myers Squibb Company (US)

Novartis AG (Switzerland)

Gilead Sciences Inc. (US)

Celgene Corporation (US)

Thermo Fisher Scientific Inc. (US)

CEVEC (Germany)

uniQure N.V. (Netherlands)

Orchard Therapeutics plc (UK)

Gene Therapy Market Highlights:

Gene Therapy Market Size

Gene Therapy Market Trends

Gene Therapy Market Analysis

Gene Therapy Market Share

Gene Therapy Market Highlights:

Gene Therapy Market Trends

Gene Therapy Market Analysis

Gene Therapy Market Share

Gene Therapy Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.